Clobetasol propionate and Orencia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clobetasol propionate (clobetasol propionate) and Orencia (abatacept). Common drug interactions include drug ineffective among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Clobetasol propionate and Orencia. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Clobetasol propionate?

Clobetasol propionate has active ingredients of clobetasol propionate. It is often used in psoriasis. eHealthMe is studying from 10,661 Clobetasol propionate users. Check the latest studies of Clobetasol propionate.

What is Orencia?

Orencia has active ingredients of abatacept. It is often used in rheumatoid arthritis. eHealthMe is studying from 135,415 Orencia users. Check the latest studies of Orencia.



On Jul, 10, 2026

36 people who take Clobetasol propionate and Orencia together, and have interactions are studied.

Clobetasol propionate and Orencia drug interactions.

What are the common drug interactions of Clobetasol Propionate and Orencia, by gender? *:

female:

  1. Drug ineffective
  2. Headache (pain in head)
  3. Sinusitis (inflammation of sinus)
  4. Fatigue (feeling of tiredness)
  5. Influenza like illness
  6. Fungal infection
  7. Drug hypersensitivity
  8. Dyspnoea (difficult or laboured respiration)
  9. Pyrexia (fever)
  10. Arthralgia (joint pain)

male:

  1. Alanine aminotransferase increased
  2. Arthropathy
  3. Tinea cruris (an infection of the groin caused by a fungus)
  4. Urticaria (rash of round, red welts on the skin that itch intensely)
  5. Anaphylactic reaction (serious allergic reaction)
  6. Staphylococcal infection (an infection with staphylococcus bacteria)
  7. Aspartate aminotransferase increased
  8. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  9. Drug hypersensitivity
  10. Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Clobetasol Propionate and Orencia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Device expulsion
  2. Muscle spasms (muscle contraction)

30-39:

n/a

40-49:

  1. Alanine aminotransferase increased
  2. Arthropathy
  3. Aspartate aminotransferase increased
  4. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  5. Drug hypersensitivity
  6. Dyspnoea (difficult or laboured respiration)
  7. Food allergy
  8. Genital discomfort
  9. Insomnia (sleeplessness)
  10. Intervertebral disc protrusion (spinal disc protrusion)

50-59:

  1. Staphylococcal infection (an infection with staphylococcus bacteria)
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

60+:

  1. Arthralgia (joint pain)
  2. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Oral herpes (viral infection of mouth)
  5. Pruritus (severe itching of the skin)
  6. Rhinorrhoea (watery mucus discharge from the nose)
  7. Seasonal allergy (allergic condition due to certain season)
  8. Sinusitis (inflammation of sinus)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 14 people, 38.89%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 11.11%
  3. Systemic Mastocytosis (a condition caused by the accumulation of mast cells in more than one part of the body): 3 people, 8.33%
  4. Immune System Disorder: 3 people, 8.33%
  5. Dry Eyes (lack of adequate tears): 3 people, 8.33%
  6. Diarrhea: 3 people, 8.33%
  7. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 5.56%
  8. Pain: 2 people, 5.56%
  9. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 5.56%
  10. Birth Control: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Clobetasol propionate and Orencia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clobetasol propionate and Orencia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clobetasol propionate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Orencia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clobetasol propionate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Orencia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clobetasol propionate and abatacept (the active ingredients of Clobetasol propionate and Orencia, respectively), and Clobetasol propionate and Orencia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: